Zobrazeno 1 - 10
of 23
pro vyhledávání: '"N. F. Milanovich"'
Publikováno v:
Doklady Belorusskogo gosudarstvennogo universiteta informatiki i radioèlektroniki, Vol 0, Iss 7, Pp 274-277 (2019)
Using the fluorescent probes method the conformational changes in albumin have been found in case of chemotherapy high dozes applied for treatment of patients with acute myeloid leukemia, as well as the inflammatory process has been decreased after t
Externí odkaz:
https://doaj.org/article/3e4e3df95c8d4ec68583c9f61107c40c
Autor:
N. V. Zhukov, A. L. Uss, N. F. Milanovich, V. V. Ptushkin, B. V. Afanasiev, N. B. Mikhaylova, V. B. Larionova, Ye. A. Demina, N. G. Tyurina, M. A. Vernyuk, Ye. Ye. Karamanesht, A. G. Rumyantsev
Publikováno v:
Онкогематология, Vol 9, Iss 3, Pp 32-40 (2015)
The influence of previous antitumor therapy the efficacy and tolerability of high-dose chemotherapy with autologous hematopoietic progenitor cells transplantation (HCST) in 369 patients with Hodgkin, s lymphoma in the clinics of Russia and CIS countr
Externí odkaz:
https://doaj.org/article/9e6e7f17fa354ebf9f9c5a8190d253ae
Autor:
N. V. Zhukov, A. L. Uss, N. F. Milanovich, V. V. Ptushkin, B. V. Afanasiev, N. B. Mikhaylova, V. B. Larionova, E. A. Demina, N. G. Tyurina, M. A. Vernyuk, E. E. Karamanesht, A. G. Rumyantsev
Publikováno v:
Онкогематология, Vol 9, Iss 2, Pp 37-44 (2014)
Autologous hematopoietic stem cell transplantation (HSCT) is the standard treatment for patients with relapsed and primary refractoryHodgkin's lymphoma (HL). According to current recommendations HSCT must be performed in first relapse or after regist
Externí odkaz:
https://doaj.org/article/a6a5819cace74f079c937d2e1c275049
Autor:
N. V. Zhukov, A. L. Uss, N. F. Milanovich, V. V. Ptushkin, B. V. Afanasyev, N. B. Mikhaylova, V. B. Larionova, E. A. Demina, E. E. Karamanesht, N. G. Tyurina, O. A. Pavlova, A. G. Rumyantsev, A. D. Kaprin
Publikováno v:
Онкогематология, Vol 8, Iss 3, Pp 35-41 (2014)
Traditionally, the concern of fatal complication is a major obstacle to transfer patients with unfavorable course of Hodgkin’s lymphoma tonational transplantation centers. Early mortality after high-dose chemotherapy with autologous hematopoietic s
Externí odkaz:
https://doaj.org/article/f6115523b8514ec88678b6e2d7768b68
Publikováno v:
Інфекційні хвороби.
Представлено результати оригінального дослідження, присвяченого визначенню чинників ризику розвитку бактерійних інфекційних ускладн
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d4dd8d4bbd4915411fcdf5717224ebe
https://doi.org/10.11603/1681-2727.2016.2.6521
https://doi.org/10.11603/1681-2727.2016.2.6521
Autor:
N. F. Milanovich
Publikováno v:
Health and Ecology Issues. :61-64
The present-day approaches to the treatment for chronic lymphatic leukemia have been considered, the application of rituximab, monoclonal antibody to СD20-receptors has been grounded. The results of the retrospective analysis and randomized clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b59a493a53998a5160c666c1b8fc2141
https://doi.org/10.51523/2708-6011.2011-8-2s-20
https://doi.org/10.51523/2708-6011.2011-8-2s-20
Publikováno v:
Health and Ecology Issues. :87-89
The article presents the results in the analysis of the quality of specialized medical assistance to patients with hemopoietic diseases in the Republic of Belarus. The structure of the hematological service, availability with bed fund, specialists, l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5035b8996003512e8ec3985c9547af6b
https://doi.org/10.51523/2708-6011.2011-8-2s-31
https://doi.org/10.51523/2708-6011.2011-8-2s-31
Publikováno v:
Health and Ecology Issues. :64-66
176 oncohematologic patients, their sibs and 200 blood donors were examined to determine the possibility for related and unrelated donor for hemapoietic stem cell transplantation. HLA antigens I and II were indentified and frequency of occurrence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19e1083d7cee8a745d9c0aa3ba5d5b36
https://doi.org/10.51523/2708-6011.2011-8-2s-21
https://doi.org/10.51523/2708-6011.2011-8-2s-21
Publikováno v:
Health and Ecology Issues. :57-59
The restoration of hemopeisis indices after high dose chemotherapy with autologic and allogenic transplantation of stem hemopoeitic cells with the combined use of hemopoietic growth factors - erythropoietin and granulocytic colony-stimulating factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac34539c5655d735cb851eae0e8651d9
https://doi.org/10.51523/2708-6011.2011-8-2s-18
https://doi.org/10.51523/2708-6011.2011-8-2s-18
Autor:
A L, Uss, V A, Zmachinskiĭ, N F, Milanovich, A E, Skriagin, E V, Dziuba, S V, Vlasenkova, N S, Solov'eva, Z E, Batan, P B, Mitskevich, I L, Zavgorodniaia, O V, Aleĭnikova, E A, Zhavrid
Publikováno v:
Voprosy onkologii. 46(5)
In 1995-1999, 67 patients with relapsed Hodgkin's disease or refractory to chemotherapy (group A--first relapse, B--primary refractory disease, and C--repeated relapse) received cytoreductive (dexaBEAM, DHAP) therapy followed by high-dose BEAM chemot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3bcf08bd7819e9c1ad9ad40051383772
https://pubmed.ncbi.nlm.nih.gov/11202200
https://pubmed.ncbi.nlm.nih.gov/11202200